Intellia Therapeutics Announces First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Intellia Therapeutics Announces First Quarter 2021 Financial Results

Intellia Therapeutics (NTLA) Misses Q1 EPS by 3c, Revenues Miss

May 6, 2021 7:40 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q1 EPS of ($0.69), $0.03 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $6.45 million versus the consensus estimate of $9.86 million.

Intellia continues to build momentum as we progress our full-spectrum pipeline towards key upcoming milestones... More